Guidance

Reflex (genotyping) assays for identification of priority SARS-CoV-2 variants of concern

Information on the use of reflex (genotyping) assays for identification of priority SARS-CoV-2 variants of concern.

From:
UK Health Security Agency
Published
15 July 2021
Last updated
20 April 2022 — See all updates

Documents

Reflex (genotyping) assays for identification of priority SARS-CoV-2 variants of concern

HTML

Details

Reflex (genotyping) assays comprise of nucleotide primers and probes to identify the presence of specific mutations in SARS-CoV-2 positive samples. The detection of mutations is indicative of infection with a variant of concern.

This document offers guidance on the use of reflex assays for identification of priority SARS-CoV-2 variants of concern.

Updates to this page

Published 15 July 2021
Last updated 20 April 2022 + show all updates

  1. Updated guidance.

  2. First published.

Sign up for emails or print this page

Related content